Humana Inc. (HUM) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
HUM Revenue Growth
Revenue Breakdown (FY 2025)
HUM's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
HUM Revenue Analysis (2014–2025)
As of May 6, 2026, Humana Inc. (HUM) generated trailing twelve-month (TTM) revenue of $137.20 billion, reflecting exceptional growth of +23.5% year-over-year. The most recent quarter (Q1 2026) recorded $39.65 billion in revenue, up 21.9% sequentially.
Looking at the longer-term picture, HUM's 5-year compound annual growth rate (CAGR) stands at +10.9%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $129.66 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows HUM's business is primarily driven by Insurance Segment (85%), and CenterWell Segment (15%). With over half of revenue concentrated in Insurance Segment, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including UNH (+9.7% YoY), CVS (+7.8% YoY), and ELV (+9.4% YoY), HUM has outperformed the peer group in terms of revenue growth. Compare HUM vs UNH →
HUM Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| $137.2B | +23.5% | +10.9% | 1.1% | ||
| $447.6B | +9.7% | +11.7% | 4.2% | ||
| $402.1B | +7.8% | +8.4% | 2.6% | ||
| $199.1B | +9.4% | +10.3% | 4.1% | ||
| $194.8B | +17.0% | +11.9% | -3.9% | ||
| $45.4B | +7.7% | +18.5% | 1.7% |
HUM Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $129.66B | +10.1% | $18.85B | 14.5% | $1.45B | 1.1% |
| 2024 | $117.81B | +10.7% | $17.15B | 14.6% | $1.63B | 1.4% |
| 2023 | $106.44B | +14.5% | $18.05B | 17.0% | $3.32B | 3.1% |
| 2022 | $92.92B | +11.1% | $17.23B | 18.5% | $3.56B | 3.8% |
| 2021 | $83.65B | +8.4% | $14.45B | 17.3% | $3.42B | 4.1% |
| 2020 | $77.19B | +18.9% | $15.69B | 20.3% | $4.67B | 6.1% |
| 2019 | $64.93B | +14.0% | $11.19B | 17.2% | $3.47B | 5.3% |
| 2018 | $56.94B | +5.8% | $11.19B | 19.7% | $2.07B | 3.6% |
| 2017 | $53.80B | -1.1% | $7.08B | 13.2% | $3.33B | 6.2% |
| 2016 | $54.41B | +0.2% | $7.77B | 14.3% | $1.74B | 3.2% |
Full HUM Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See HUM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HUM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare HUM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonHUM — Frequently Asked Questions
Quick answers to the most common questions about buying HUM stock.
Is HUM's revenue growth accelerating or slowing?
HUM revenue is accelerating at +23.5% year-over-year, exceeding the 5-year CAGR of +10.9%. TTM revenue reached $137.2B. Growth momentum has increased versus prior periods.
What is HUM's long-term revenue growth rate?
Humana Inc.'s 5-year revenue CAGR of +10.9% reflects the sustained expansion pattern. Current YoY growth of +23.5% is above this long-term average.
How is HUM's revenue distributed by segment?
HUM reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.